![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.461, 2004-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Latest guidance issued by UK NICE
Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insufficient evidence behind latest UK NICE guidance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Guidance on somatropin use in GH deficiency issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Doxorubicin liposomal in ovarian cancer guidance issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-D-Rh0 immunoglobulin guidance issued by UK NICE
Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. :